CurrentCardio
Get Weekly

Topic · page 3 of 21

Prevention & lipids

Lipids, Lp(a), lifestyle (activity, diet, alcohol, smoking), risk scores, primary prevention in general or older populations, frailty and CV risk

Briefs 81–120 of 838 placed here, newest publication first

Briefs in Prevention & lipids

Newest publication first

  1. JACC Adv

    PPV23 Vaccination and Risk of Cardiovascular Events: A Meta-Analysis

    Meta-analysis

  2. Eur Heart J

    Immunological risk identified by single-cell multi-omics and cardiovascular outcomes

    Case-control study

  3. J Am Coll Cardiol

    Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes: Results From the Cross-Cohort Collaboration

    Cohort study

  4. JACC Adv

    FIND Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease

    Cohort study

  5. J Am Coll Cardiol

    Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology

    Guideline or statement

  6. Eur J Prev Cardiol

    Predicted 10-year cardiovascular disease risk reduction with tirzepatide use over 3 years for primary prevention of cardiovascular disease in obesity

    Secondary analysis

  7. Eur Heart J

    Bruton’s tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis

    Meta-analysis

  8. JACC Adv

    Cardiorespiratory Fitness, Coronary Artery Calcium, and Risk of Later-Life Dementia: The Cooper Center Longitudinal Study

    Research article

  9. Am Heart J

    HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics

    Trial design

  10. Circ Popul Health Outcomes

    External Validation of the PREVENT Equations in a National Sample of US Adults

    Diagnostic or prognostic study

  11. JACC Adv

    Social Drivers of Health Advisory: Cardiovascular Disease Projections Through 2050

    Research article

  12. JAMA Cardiol

    Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis

    Cohort study

  13. Eur J Prev Cardiol

    Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank

    Cohort study

  14. Circ Popul Health Outcomes

    Comparison of Lipid Results From 2007 to 2009 via Commercial Clinical Laboratory Testing Versus a Population-Based Cohort: Proof-of-Concept for Population Health Monitoring of Lipids Using Commercial Lab Data

    Cohort study

  15. JACC Adv

    County-Level Geographic Access and Cardiovascular Disease Outcomes in Washington State

    Research article

  16. J Am Coll Cardiol

    Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease

    Cohort study

  17. Eur J Prev Cardiol

    Global trends in key modifiable cardiovascular risk factors: a joinpoint analysis across WHO regions (1990–2022)

    Research article

  18. J Am Coll Cardiol

    Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults

    Cross-sectional study

  19. Eur J Prev Cardiol

    Association of cancer incidence and cancer-related mortality with statin therapy, ezetimibe, and statin–ezetimibe combination: a systematic review and Bayesian network meta-analysis of randomized controlled trials

    Meta-analysis

  20. Circulation

    Predictive Value of Coronary Artery Calcium Score From Nongated Chest CT Scans Compared With Gated Scans and Incidence of Cardiovascular Events

    Cohort study

  21. JACC Adv

    Cardiovascular Disease Screening Programs in Low- and Middle-Income Countries: A Systematic Review

    Meta-analysis

  22. Eur J Prev Cardiol

    Nutritional interventions in cardiac rehabilitation: current evidence, evidence gaps, and future directions—a scoping review

    Research article

  23. JACC Adv

    Zero Coronary Artery Calcium as a Marker of Vascular Resilience in High-Risk Adults

    Research article

  24. Circulation

    Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statement

  25. JACC Cardiovasc Imaging

    Association of Lipoprotein(a) With Coronary Atherosclerosis and Cardiovascular Events: Findings From the SCAPIS Cohort

    Cohort study

  26. J Am Coll Cardiol

    The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association’s PREVENT Calculator: Insights From MESA

    Cohort study

  27. Eur J Prev Cardiol

    Effect of dietary counselling on educational disparities in cardiometabolic health from childhood to adulthood

    Secondary analysis

  28. JACC Adv

    Secular Trends in Lipid Management Among U.S. Veterans With Atherosclerotic Cardiovascular Disease, 2003 to 2020

    Cohort study

  29. Am Heart J

    Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: A descriptive compatibility analysis

    Research article

  30. Am Heart J

    Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)

    Cohort study

  31. JACC Adv

    Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial

    Secondary analysis

  32. Eur J Prev Cardiol

    Cardiovascular risk in inflamed Danish women and men without standard modifiable risk factors

    Cohort study

  33. Eur J Prev Cardiol

    External validation and head-to-head comparison of CUORE and SCORE2 cardiovascular risk scores in an Italian primary care-administrative cohort

    Cohort study

  34. Eur Heart J

    Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation

    Diagnostic or prognostic study

  35. Eur Heart J

    Peri-aortic fat to assess cardiovascular aging using an AI-driven radiomic biomarker

    Cohort study

  36. Circulation

    Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association

    Guideline or statement

  37. JACC Cardiovasc Imaging

    Serial Changes in Epicardial Adipose Tissue Attenuation Identify Residual Atherosclerotic Risk Independent of LDL Lowering: A Post Hoc Analysis of the CAUGHT-CAD Trial

    Secondary analysis

  38. Am Heart J

    Revised lipid-lowering therapy guidelines in a nationally representative sample

    Cross-sectional study

  39. Circ Cardiovasc Imaging

    Automated AI-Based Aortic Measurements From Attenuation Correction CT as an Adjunctive Cardiovascular Risk Biomarker: An International Multicenter Study

    Research article

  40. Circ Popul Health Outcomes

    Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE

    Secondary analysis

All 838 Briefs in ExploreShowing Briefs 81–120 of 838, newest first